Guerbet brings Vectorio to Canadian market

2019 12 18 19 15 2524 Guerbet Rsna 2019 400

Contrast developer Guerbet has received approval to market its Vectorio contrast media kit in Canada for imaging of hepatocellular carcinoma (HCC).

A mixing and injection system for administering Guerbet's Lipiodol Ultra Fluid Injection, Vectorio facilitates imaging of liver tumors in adults with known HCC during interventional oncology procedures, according to the vendor.

Page 1 of 543
Next Page